HealthChina drug regulator accepts Novo Nordisk application for oral Wegovy

China’s drug regulator has accepted Novo Nordisk’s application to market an oral version of the Danish drugmaker’s weight-loss medicine Wegovy, the company said.

Novo NordiskWegovyChina drug regulatorweight-loss drug

RReuters★★☆☆☆2026-08-27 04:10Original